TP53 and central nervous system cancer: In this work, we employ LFS iPSC-derived astrocytes to explore the oncogenic function of mutant p53 in glioma initiation and integrate multilayered regulatory analyses to investigate the epitranscriptomic consequences of mutant p53 gain-of-function.